CorMedix, Inc. (CRMD)
11.72
+0.24
(+2.14%)
USD |
NASDAQ |
Dec 11, 16:00
11.72
0.00 (0.00%)
After-Hours: 18:48
CorMedix Research and Development Expense (Quarterly): 5.098M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Pfizer Inc. | 2.492B |
| ANI Pharmaceuticals, Inc. | 12.30M |
| Arcutis Biotherapeutics, Inc. | 19.60M |
| Alkermes Plc | 80.34M |
| Talphera, Inc. | 1.803M |